SEQENS Group
- Home
- Companies
- SEQENS Group
- Products
- Sitagliptin Phosphate Monohydrate
Sitagliptin Phosphate Monohydrate
FromSEQENS Group
Sitagliptin is an oral dipeptidyl peptidase-4 (DPP-4) inhibitor used in conjunction with diet and exercise to improve glycemic control in patients with type 2 diabetes mellitus. The effect of this medication leads to glucose dependent increases in insulin and decreases in glucagon to improve control of blood sugar.
Most popular related searches
- Product Name: Sitagliptin Phosphate Anhydrous
- CAS Number: 654671-78-0
- Therapeutic Class: Antidiabetic
- Dosage Form: Oral Tablets
- Availability: Under Development
- Regulatory Status